Investors are on the edge of their collective seats, hoping that Genesco
What analysts say:
- Buy, sell, or hold?: Analysts strongly back Genesco, with eight of nine rating it a buy and the remainder rating it a hold. Analysts don't like Genesco as much as competitor Finish Line overall. While analysts still rate the stock a Moderate buy, they are a little more optimistic about it compared to three months ago.
- Revenue Forecasts: On average, analysts predict $585.7 million in revenue this quarter. That would represent a rise of 26% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of 95 cents per share. Estimates range from 88 cents to 99 cents.
What our community says:
CAPS All Stars are solidly backing the stock with 92% assigning it an "outperform" rating. The community at large concurs with the All Stars with 86.7% granting it a rating of "outperform." Fools are keen on Genesco, though the message boards have been quiet lately with only 60 posts in the past 30 days. Despite the majority sentiment in favor of Genesco, the stock has a middling CAPS rating of three out of five stars.
One final thing: If you want to keep tabs on Genesco movements, and for more analysis on the company, make sure you add it to your Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks